In 1991, the National Academy of Sciences (NAS) published a report, Monitoring Human Tissues for Toxic Substances, which presented a summary of thinking about the banking of human tissue specimens at the time the report was completed. The present article summarizes the findings and recommendations in the NAS report. Events have moved very rapidly since that time, but some history may be helpful in understanding how we have come to where we are today. -Environ Health Perspect 103(Suppl 3): 81-84 (1995) 
bers might say today, but readers should understand that I may have erred.
The report is still less than 4 years old, but many of its Many toxic substances in the environment, including synthetic chemicals, pose hazards to human health, but monitoring human exposures can be difficult. Many substances move readily from one environmental medium to another, and reliable monitoring data are sparse for most routes of human exposure. Furthermore, monitoring the environment by identifying and measuring concentrations of chemicals in environmental media (e.g., air, water, and soil) is not by itself an adequate basis for assessing human exposures.
Determining the concentrations of specific chemicals in human tissues, such as blood and adipose tissue, can serve in effect to integrate many kinds of human exposures across media and time. A well-designed national program to monitor toxic chemicals in human tissues is a necessary component of an anticipatory strategy aimed at early identification of and response to health and environmental problems concerning xenobiotic toxicants in the environment.
The National Human Monitoring Program (NHMP) was The quantities of chemicals present in various media can be used to determine which of those media may be potential routes of exposure; however, such measurements are not necessarily reflected in tissue concentrations. Tissue chemical measurements must be supplemented with knowledge of contaminant sources, environmental pathways, environmental concentrations, time patterns and locations of exposure, routes of entry into the body, material toxicity, and latency.
It is not feasible to study a broad range of tissues in a general population sample. Instead, attempts must be made to identify tissues that most nearly account for the body burden of most of the chemicals of concern. When the NHATS was designed, pesticides were of greatest concern, especially chlorinated aromatic hydrocarbons, which tend to accumulate in adipose tissues. New trends in environmental exposures, advances in analytic chemistry, increased sensitivity of equipment, and the discontinuation of the use of most halogenated aromatic hydrocarbons as pesticides and many halogenated aromatic industrial chemicals make the study of other tissues important as well as feasible. The committee considered the collection of blood as well as other tissues and specimens, including lean tissue, hair, urine, and some other biologic fluids.
The present evidence led the committee to conclude that the basis of a humantissue monitoring program should be broad, random collection of blood samples, supplemented by the continued collection of adipose tissue.
While blood and adipose tissue are being collected, the program should undertake research on how the chemical measure of a xenobiotic toxicant in one tissue is correlated with that in another, so that the effects of nonrandomness in the adipose samples will be better understood and the continued contribution of the adipose samples (including stored samples) can be evaluated properly.
Regardless of the tissues collected, samples should be accompanied by standardized information on demographics, illness (especially terminal illness), and known occupational or other major exposures to chemicals.
High priority should be given to the collection of matched adipose and blood specimens for future parallel analyses. Matched specimens of fat from different anatomic regions also might be useful.
If the NHATS were replaced, as the committee recommends, with a blood monitoring program as the primary method of measuring toxic substances in human tissue, the sampling plan should be patterned after the one used in National Health and Nutrition Examination Survey, which includes a close approximation to a probability sample of the U.S. population.
Blood specimens should be collected in strict accordance with the method of probability sampling at all stages. The methods used should be efficient for giving virtually all persons in the United States a known probability of selection.
Such a system also would permit interviews with the sampled persons to obtain data on covariates.
Many The committee firmly recommends that monitoring be kept strictly independent of regulation itself.
The committee concludes that considerations of input to policy, impact, visibility, and independence argue for a location at the highest feasible organizational level.
A location that is geographically close to other programs and laboratories active in relevant technical disciplines would facilitate important exchanges about methods, as well as follow-up of findings.
The critical resources in a program of monitoring human tissues include funding and expertise in appropriate scientific fields. Sufficient funding, with assurance that it will remain adequate over the next few years, is essential. However, the final budget for a program should be determined after the program specifications have been formulated. The major factors involved in determining funding are the annual sample size, the set of chemical assays to be performed, the type of tissue to be collected, the size of the staff needed to monitor the program and analyze results, and requirements for research and development. Funding is flexible to a certain point. However, there is a minimum level of funding below which the program would not be worthwhile; and obviously, the greater the funding, the more informative the analyses that can be conducted.
Although the committee did not undertake detailed cost analyses, it believed that the U.S. EPA's history as well as the operation of other tissue-monitoring programs suggest that $5 million per year, exclusive of staff salaries and overhead, could support a substantial flow of high-quality, policy-relevant information. This level still is not munificent support, but it might be sufficient to serve U.S. EPA's policy needs and bring some critical distinction to the program. Furthermore, it could be used to develop a solid base of competence, experience, and usefulness to support possible expansion in the future.
Greater financial support-even up to the 25 to $50 million per year suggested by heads of other agencies-could be put to good use, given appropriate planning and the organizational setting and mission described in the NAS report. However, such allocations did not appear feasible at that time, so the committee did not explore their implications.
The Some professional staff members should be fully dedicated to the program, without competing duties.
The committee specifically recommends that the program be designed in a modular fashion as much as possible to permit critical core activities to be maintained even if other activities must be curtailed, suspended, or ended at some future time.
A structured approach to basic and more exploratory data analysis is needed. The program must produce timely reports regularly.
The committee recommends that at a minimum, an annual report of basic analyses should be produced within a year of completion of the sample collection.
Reports should, and almost certainly will, undergo internal review. Extra-agency review of draft reports is also desirable, especially peer review by persons on the scientific advisory panel and perhaps other persons with specific expertise.
A human-tissue monitoring program should be designed as a multiple-user service activity. That creates substantial obligations for assisting users to understand what the program does and does not provide, for timely analysis and publication of results, for specific and helpful guidance in access to archived specimens, and for active "marketing" of products, that is, promoting the use of both data and specimens.
A well-defined process for producing a range of outputs is an important part of the planning effort. A schedule should be widely and continually publicized and should be relaxed only under the most compelling circumstances. Scientific staff, who bear most of the responsibility for meeting a schedule, should recognize that timely, high-quality reports on important matters are a sine qua non.
A specific person or persons must be responsible for outreach efforts, which are warranted by the multiuse nature of the program, the wide-ranging interest in the resulting data, and the clear indications that more passive approaches to publicizing program reports have failed to reach some critical target groups.
A tissue-monitoring and archival program must cooperate and communicate with other branches of U.S. EPA, other government agencies, academic and private sectors, and foreign environmental programs. Not only are such cooperation and information exchanges important in the operation of human-tissue monitoring, but continuing information exchange will be critical to the efficient operation of the new program.
The committee concluded that special value might be found in the joint development of a small set of measurements to be made in similar ways across a broad range of programs, as a means of establishing comparability among programs that could lead to a worldwide database for environmental toxicants that persist over long times or migrate across long distances and across national boundaries.
It is heartening to see the progress that has already been made toward the development of a program for monitoring toxic substances in human tissues.
